Share This

Create Your Own Business Intelligence Website   Input the stock code or the company name     Search   <06185.HK> - CANSINO BIOLOGICS INC.    Stock Screener：Biotechnology, Biotechnology HUTCHMED INNOVATIVE PHAR UNI-BIO GROUP KING INTL INV BBI LIFE SCI ESSEX BIO-TECH JACOBIO-B CANBRIDGE-B 3D MEDICINES FUDANZHANGJIANG OCUMENSION-B FRONTAGE 3SBIO IMMUNEONCO-B GENSCRIPT BIO ASCLETIS-B INNOVENT BIO VIVA BIOTECH TOT BIOPHARM-B JUNSHI BIO EVEREST MED-B LAEKNA-B JW THERAP-B BRII-B HBM HOLDINGS-B LEPU BIO-B KEYMED BIO-B BASECARE-B CARSGEN-B RECBIO-B MABPHARM-B CLOVER BIO-B ABBISKO-B SIRNAOMICS-B WUXI XDC WUXI BIO BIOCYTOGEN-B MEILLEUREHEALTH WUXI APPTEC GIANT BIOGENE LUZHU BIOTECH-B CUTIA-B YZYBIO-B QYUNS-B HIGHTIDE-B HUA MEDICINE-B CSTONE PHARMA-B HENLIUS TIGERMED SINOMAB BIO-B CT ENTERPRISE AUSTAR JOINN BEIGENE SCICLONE PHARMA TRANSCENTA-B AIM VACCINE MEGA GENOMICS HAOHAI BIOTEC ASCENTAGE-B BOAN BIOTECH IMMUNOTECH-B SKB BIO-B ANTENGENE-B GENOR-B HAO WEN HLDGS HK LIFE SCI CRMI PFC DEVICE BIOSINO BIO-TEC NEP INTERLONG CORNERSTONE TEC HUAKANG BIOMED    Basic Datum Company name Lot P/E P/B EPS DPS CANSINOBIO 200 -3.57 0.7584 -6.5882 0.0 Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend    Related links    Related news   ≫More    Company Rating Date Broker Company name Rating Target 01-12  CLSA   CANSINOBIO  買入 29 ≫More    Company performance - Published Date Company name Turnover* Profit* % Dividend ≫More    Comment 2022-09-13　康希諾生物（6185）近期推出霧化吸入使用的5型腺病毒載體（Ad5-nCoV）預防新冠肺炎疫苗，最近獲內地藥監局納入緊急使用範圍。因疫情邁向流感化下，新疫苗可作加強劑使用。   2022-09-13　康希諾生物「克威莎霧優」新冠肺炎疫苗可支持滅活及其他疫苗，作為第四針甚至第五針加強劑去應用。新疫苗在激發體液免疫及細胞免疫之外，亦實現誘導黏膜免疫，可調動肺部免疫體系，可進一步加強預防功能，因此有助日後用同一思路作更多產品開發。至於其開發的mRNA新冠疫苗產品，則已進入臨床二期階段，他形容進展非常順利。      Top Gain / Loss Show All Charts     Value Name Updated Value Change Change % HSI 04-17 09:30 16271.2 ▲ 22.23 ▲ 0.14% CANSINOBIO 04-19 16:08 16.5 ▲ 16.5 ▲ ∞% ≫More

Mobile | Full

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map

Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved

Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.